Behavioral and cross sensitization after repeated exposure to modafinil and apomorphine in rats

Chinese Journal of Physiology

Volumn 53, Issue 5, 2010, Pages 318-327

  Chang, Shang Tang ^b   Tung, Che Se ^a   Lin, Yu Lung ^a   Chuang, Chia Hsin ^b   Lee, An Rong ^a   Liu, Yia Ping ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

APO; Behavioral sensitization; Cross sensitization; Dopamine; MOD

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MODAFINIL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SENSITIZATION; CONTROLLED STUDY; CROSS ALLERGY; DOPAMINERGIC ACTIVITY; DRUG ABUSE PATTERN; DRUG ANTAGONISM; DRUG REEXPOSURE; DRUG RESPONSE; LOCOMOTION; MALE; MOTOR ACTIVITY; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSITIZATION; STEREOTYPY;

EID: 78149452299     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2010.AMK067     Document Type: Article

References (42)

1. Akimoto, K., Hamamura, T., Kazahaya, Y., Akiyama, K. and Otsuki, S. Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine-an in vivo dialysis study in freely moving rats. Brain Res. 507: 344-346, 1990.
2. Ballon, J.S. and Feifel, D. A systematic review of modafinil: Potential clinical uses and mechanisms of action. J. Clin. Psychiatry 67: 554-566, 2006.
3. Battisti, J.J., Uretsky, N.J. and Wallace, L.J. Sensitization of apomorphine-induced stereotyped behavior in mice is context dependent. Psychopharmacology (Berl) 146: 42-48, 1999.
4. Castro, R., Abreu, P., Calzadilla, C.H. and Rodriguez, M. Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval. Psychopharmacology (Berl) 85: 333-339, 1985.
5. Chen, C.R., Qu, W.M., Qiu, M.H., Xu, X.H., Yao, M.H., Urade, Y. and Huang, Z.L. Modafinil exerts a dose-dependent antiepileptic effect mediated by adrenergic alpha1 and histaminergic H1 receptors in mice. Neuropharmacology 53: 534-541, 2007.
6. Dackis, C.A., Kampman, K.M., Lynch, K.G., Pettinati, H.M. and O'Brien, C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30: 205-211, 2005.
7. De Sereville, J.E., Boer, C., Rambert, F.A. and Duteil, J. Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies. Neuropharmacology 33: 755-761, 1994.
8. Deroche-Gamonet, V., Darnaudery, M., Bruins-Slot, L., Piat, F., Le Moal, M. and Piazza, P.V. Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology (Berl) 161: 387-395, 2002.
9. Duteil, J., Rambert, F.A., Pessonnier, J., Hermant, J.F., Gombert, R. and Assous, E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur. J. Pharmacol. 180: 49-58, 1990.
10. Edgar, D.M. and Seidel, W.F. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. J. Pharmacol. Exp. Ther. 283: 757-769, 1997.
11. Engber, T.M., Dennis, S.A., Jones, B.E., Miller, M.S. and Contreras, P.C. Brain regional substrates for the actions of the novel wakepromoting agent modafinil in the rat: comparison with amphetamine. Neuroscience 87: 905-911, 1998.
12. Ferraro, L., Tanganelli, S., O'Connor, W.T., Antonelli, T., Rambert, F. and Fuxe, K. The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur. J. Pharmacol. 306: 33-39, 1996.
13. Goeders, N.E. The impact of stress on addiction. Eur. Neuropsychopharmacol. 13: 435-441, 2003.
14. Jasinski, D.R. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J. Psychopharmacol. 14: 53-60, 2000.
15. Karila, L., Gorelick, D., Weinstein, A., Noble, F., Benyamina, A., Coscas, S., Blecha, L., Lowenstein, W., Martinot, J.L., Reynaud, M. and Lepine, J.P. New treatments for cocaine dependence: a focused review. Int. J. Neuropsychopharmacol. 11: 425-438, 2008.
16. Kauer, J.A. and Malenka, R.C. Synaptic plasticity and addiction. Nat. Rev. Neurosci. 8: 844-858, 2007.
17. Kinon, B.J., Merson, D. and Kane, J.M. Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat. Psychopharmacology (Berl) 84: 347-351, 1984.
18. Kruszewski, S.P. Euphorigenic and abusive properties of modafinil. Am. J. Psychiatry 163: 549, 2006.
19. Kumar, R. Approved and investigational uses of modafinil: an evidence-based review. Drugs 68: 1803-1839, 2008.
20. Laudrup, P. and Wallace, L.J. Sensitization elicited by directly and indirectly acting dopaminergic agonists: comparison using neural network analysis. Psychopharmacology (Berl) 141: 169-174, 1999.
21. Liao, R.M. and Lin, H.L. Differential effects of lesions in the subareas of medial prefrontal cortex on the development of behavioral sensitization to amphetamine: the role of environmental context. Chinese. J. Physiol. 51: 394-401, 2008.
22. Mattingly, B.A. and Rowlett, J.K. Effects of repeated apomorphine and haloperidol treatments on subsequent behavioral sensitivity to apomorphine. Pharmacol. Biochem. Behav. 34: 345-347, 1989.
23. Mattingly, B.A., Caudill, A. and Abel, M. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine. Pharmacol. Biochem. Behav. 68: 417-426, 2001.
24. Mejias-Aponte, C.A., Drouin, C. and Aston-Jones, G. Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J. Neurosci. 29: 3613-3626, 2009.
25. Mitchell, H.A., Bogenpohl, J.W., Liles, L.C., Epstein, M.P., Bozyczko-Coyne, D., Williams, M. and Weinshenker, D. Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action. Pharmacol. Biochem. Behav. 91: 217-222, 2008.
26. Murillo-Rodriguez, E., Haro, R., Palomero-Rivero, M., Millan-Aldaco, D. and Drucker-Colin, R. Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav. Brain Res. 176: 353-357, 2007.
27. Pierce, R.C. and Kalivas, P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25: 192-216, 1997.
28. Randall, D.C., Shneerson, J.M., Plaha, K.K. and File, S.E. Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum. Psychopharmacol. 18: 163-173, 2003.
29. Rao, Y., Liu, Z.W., Borok, E., Rabenstein, R.L., Shanabrough, M., Lu, M., Picciotto, M.R., Horvath, T.L. and Gao, X.B. Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons. J. Clin. Invest. 117: 4022-4033, 2007.
30. Robinson, T.E. and Becker, J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396: 157-198, 1986.
31. Robinson, T.E. and Berridge, K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291, 1993.
32. Rush, C.R., Kelly, T.H., Hays, L.R., Baker, R.W. and Wooten, A.F. Acute behavioral and physiological effects of modafinil in drug abusers. Behav. Pharmacol. 13: 105-115, 2002.
33. Scammell, T.E., Estabrooke, I.V., McCarthy, M.T., Chemelli, R.M., Yanagisawa, M., Miller, M.S. and Saper, C.B. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J. Neurosci. 20: 8620-8628, 2000.
34. Shearer, J. The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev. 27: 301-308, 2008.
35. Simon, P., Hemet, C., Ramassamy, C. and Costentin, J. Nonamphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur. Neuropsychopharmacol. 5: 509-514, 1995.
36. Stoops, W.W., Lile, J.A., Fillmore, M.T., Glaser, P.E. and Rush, C.R. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology (Berl) 182: 186-193, 2005.
37. Thomas, M.J., Kalivas, P.W. and Shaham, Y. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br. J. Pharmacol. 154: 327-342, 2008.
38. Võikar, V., Soosaar, A., Volke, V., Kõks, S., Bourin, M., Männistö, P.T. and Vasar, E. Apomorphine-induced behavioural sensitization in rats: individual differences, role of dopamine and NMDA receptors. Eur. Neuropsychopharmacol. 9: 507-514, 1999.
39. Volkow, N.D., Fowler, J.S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.J., Jayne, M., Hooker, J.M., Wong, C., Hubbard, B., Carter, P., Warner, D., King, P., Shea, C., Xu, Y., Muench, L. and Apelskog-Torres, K. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. J. Am. Med. Assoc. 301: 1148-1154, 2009.
40. Wisor, J.P. and Eriksson, K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132: 1027-1034, 2005.
41. Wu, H.H., Lee, C.R., Lin, S.K., Yeh, P.H. and Pan, W.H. A single intrategmental amphetamine exposure induces transient behavioral sensitization in the rats. Chinese J. Physiol. 49: 14-21, 2006.
42. Young, J.W. Dopamine D1 and D2 receptor family contributions to modafinil-induced wakefulness. J. Neurosci. 29: 2663-2665, 2009.